BDI's renamed bronchodilators Mini Two-Way Action, Dynafed Asthma Relief on counter.
This article was originally published in The Tan Sheet
Executive Summary
BDI PHARMACEUTICALS RENAMED BRONCHODILATORS MINI TWO-WAY ACTION, DYNAFED Asthma Relief are on-counter now following the Indianapolis-based company's recent decision to drop the previous Mini Thin name for the ephedrine/guaifenesin combination products. The company also recently decided to reformulate the products to increase the amount of guaifenesin from 100 mg per dose to 200 mg, bringing them in line with agency standards for OTC expectorant products.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning